A BREAKTHROUGH case-control study has identified transcriptomic clues linking cardiotoxic cancer treatments to long-term heart disease in childhood cancer survivors. Researchers pinpointed one gene, NFE2L2, whose expression levels may…
A BREAKTHROUGH case-control study has identified transcriptomic clues linking cardiotoxic cancer treatments to long-term heart disease in childhood cancer survivors. Researchers pinpointed one gene, NFE2L2, whose expression levels may…